Reported Oct 16, 2019 · Terminated
Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC…
Mylan Laboratories Limited (Sterile Products Division)
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mylan Laboratories Limited (Sterile Products Division) · Opp. Iim-B, Bilekahalli , Bannerghatta Road · Bangalore, N/A · N/A
Is this the product you have?
- Rifampin for Injection, USP, 600 mg/vial, Rx only
- Manufactured forMylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60
- Lot codes and dates
- Lot
7008334Exp April 20207008417Exp Oct 2020
- Lot
- Amount recalled
- 19,165 vials
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mylan Laboratories Limited (Sterile Products… recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.